Virginie Supervie

1.4k total citations
41 papers, 816 citations indexed

About

Virginie Supervie is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Virginie Supervie has authored 41 papers receiving a total of 816 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Infectious Diseases, 28 papers in Epidemiology and 15 papers in Virology. Recurrent topics in Virginie Supervie's work include HIV/AIDS Research and Interventions (28 papers), HIV, Drug Use, Sexual Risk (25 papers) and HIV Research and Treatment (15 papers). Virginie Supervie is often cited by papers focused on HIV/AIDS Research and Interventions (28 papers), HIV, Drug Use, Sexual Risk (25 papers) and HIV Research and Treatment (15 papers). Virginie Supervie collaborates with scholars based in France, United States and Sweden. Virginie Supervie's co-authors include Dominique Costagliola, Sally Blower, Walid Heneine, J. Gerardo Garcı́a-Lerma, Lise Marty, Romulus Breban, Sara Lodi, Rosemary Dray‐Spira, Henri Panjo and Catherine Blanc and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Clinical Infectious Diseases and Gut.

In The Last Decade

Virginie Supervie

40 papers receiving 792 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Virginie Supervie France 17 617 492 297 158 128 41 816
Coumba Touré Kane Senegal 17 883 1.4× 596 1.2× 514 1.7× 155 1.0× 128 1.0× 50 1.3k
Vrasha Chohan United States 15 508 0.8× 265 0.5× 420 1.4× 91 0.6× 205 1.6× 22 899
Brenda Hoagland Brazil 19 885 1.4× 628 1.3× 201 0.7× 431 2.7× 243 1.9× 71 1.1k
Fernand Guédou Canada 16 497 0.8× 441 0.9× 255 0.9× 260 1.6× 203 1.6× 44 911
Debra R. Adams United States 14 851 1.4× 495 1.0× 669 2.3× 134 0.8× 114 0.9× 18 1.2k
Chawalit Natpratan United States 16 414 0.7× 346 0.7× 233 0.8× 145 0.9× 132 1.0× 29 728
Mohammed Kiddugavu Uganda 7 827 1.3× 576 1.2× 494 1.7× 181 1.1× 353 2.8× 9 1.2k
Kittipong Rungruengthanakit Thailand 16 387 0.6× 311 0.6× 220 0.7× 96 0.6× 122 1.0× 26 714
Ron A. Otten United States 18 1.3k 2.0× 566 1.2× 1.0k 3.4× 156 1.0× 157 1.2× 26 1.6k
Man Charurat United States 19 681 1.1× 428 0.9× 333 1.1× 103 0.7× 187 1.5× 48 920

Countries citing papers authored by Virginie Supervie

Since Specialization
Citations

This map shows the geographic impact of Virginie Supervie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Virginie Supervie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Virginie Supervie more than expected).

Fields of papers citing papers by Virginie Supervie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Virginie Supervie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Virginie Supervie. The network helps show where Virginie Supervie may publish in the future.

Co-authorship network of co-authors of Virginie Supervie

This figure shows the co-authorship network connecting the top 25 collaborators of Virginie Supervie. A scholar is included among the top collaborators of Virginie Supervie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Virginie Supervie. Virginie Supervie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Supervie, Virginie, Sara Croxford, Sarika Desai, et al.. (2021). HIV seroprevalence in five key populations in Europe: a systematic literature review, 2009 to 2019. Eurosurveillance. 26(47). 12 indexed citations
4.
Vaillant, L., et al.. (2020). Prévenir le VIH par la PrEP : enjeux et perspectives. La Revue de Médecine Interne. 42(4). 275–280. 2 indexed citations
5.
Nöstlinger, Christiana, Dominique Van Beckhoven, Jessika Deblonde, et al.. (2019). Identifying key elements to inform HIV-testing interventions for primary care in Belgium. Health Promotion International. 35(2). 301–311. 15 indexed citations
6.
Vourli, Georgia, Anastasia Pharris, Françoise Cazein, et al.. (2018). Are European HIV cohort data within EuroCoord representative of the diagnosed HIV population?. AIDS. 33(1). 133–143. 18 indexed citations
7.
Hales, Derek, Brian Rice, Anastasia Pharris, et al.. (2018). Monitoring the HIV continuum of care in key populations across Europe and Central Asia. HIV Medicine. 19(7). 431–439. 21 indexed citations
8.
Gourlay, Annabelle, Anastasia Pharris, Teymur Noori, et al.. (2017). Towards standardized definitions for monitoring the continuum of HIV care in Europe. AIDS. 31(15). 2053–2058. 16 indexed citations
9.
Supervie, Virginie, et al.. (2016). The diffusion dynamics of choice: From durable goods markets to fashion first names. Complexity. 21(S1). 362–369. 6 indexed citations
10.
Loû, Annabel Desgrées du, Julie Pannetier, Andrainolo Ravalihasy, et al.. (2015). HIV acquisition after arrival in France among sub-Saharan African migrants living with HIV in Paris area. Estimations from the ANRS PARCOURS study. Journal of the International AIDS Society. 18. 118–118. 3 indexed citations
11.
Loû, Annabel Desgrées du, Julie Pannetier, Andrainolo Ravalihasy, et al.. (2015). Sub-Saharan African migrants living with HIV acquired after migration, France, ANRS PARCOURS study, 2012 to 2013. Eurosurveillance. 20(46). 60 indexed citations
12.
Supervie, Virginie, et al.. (2014). The undiagnosed HIV epidemic in France and its implications for HIV screening strategies. AIDS. 28(12). 1797–1804. 60 indexed citations
13.
Supervie, Virginie, Jean‐Paul Viard, Dominique Costagliola, & Romulus Breban. (2014). Heterosexual Risk of HIV Transmission per Sexual Act Under Combined Antiretroviral Therapy: Systematic Review and Bayesian Modeling. Clinical Infectious Diseases. 59(1). 115–122. 23 indexed citations
14.
Supervie, Virginie. (2013). Les moyens de prévention de l’infection à VIH à base d’antirétroviraux. médecine/sciences. 29(4). 373–382. 2 indexed citations
15.
Descours, Benjamin, Véronique Avettand-Fènoël, Catherine Blanc, et al.. (2012). Immune Responses Driven by Protective Human Leukocyte Antigen Alleles From Long-term Nonprogressors Are Associated With Low HIV Reservoir in Central Memory CD4 T Cells. Clinical Infectious Diseases. 54(10). 1495–1503. 84 indexed citations
16.
Supervie, Virginie, et al.. (2010). Assessing the impact of mass rape on the incidence of HIV in conflict-affected countries. AIDS. 24(18). 2841–2847. 29 indexed citations
17.
Breban, Romulus, Virginie Supervie, Justin T Okano, Raffaele Vardavas, & Sally Blower. (2008). Is there any evidence that syphilis epidemics cycle?. The Lancet Infectious Diseases. 8(9). 577–581. 16 indexed citations
18.
Supervie, Virginie & Dominique Costagliola. (2007). Estimating incidence of the French BSE infection using a joint analysis of both asymptomatic and clinical BSE surveillance data. Mathematical Biosciences. 209(1). 90–107. 7 indexed citations
19.
Calavas, Didier, Virginie Supervie, Eric Morignat, Dominique Costagliola, & Christian Ducrot. (2007). Complementary Approach of Data Analysis and Modeling to Estimate the Pattern of the BSE Epidemic: The Example of France. Risk Analysis. 27(5). 1141–1150. 9 indexed citations
20.
Supervie, Virginie & Dominique Costagliola. (2004). The unrecognised French BSE epidemic. Veterinary Research. 35(3). 349–362. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026